Radium-223 Purification via DGA Extraction and Reverse Flow Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing radium-223 for pharmaceutical use face challenges in achieving high purity, efficient yield, and scalability due to contamination from long half-life actinium-227, which poses toxicity risks and requires complex and inefficient purification processes.
Innovation Solution
A method utilizing a single diglycolamide (DGA) extraction step with both forward and reverse flow to separate radium-223 from actinium-227/Thorium-227 generator mixtures, allowing for regeneration and repeated use of the generator system, thereby achieving high purity and efficient production on a commercial scale.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional purification methods are used to remove actinium-227 contamination, then purity of radium-223 is improved, but process complexity and production time increase
Solution Approach 1:
The purification process is divided into distinct functional stages: loading phase (where actinium and thorium are retained while radium passes through), washing phase (removing remaining contaminants), and elution phase (recovering purified radium). This segmentation allows each stage to be optimized independently, achieving high purity with a manageable multi-step process rather than a single complex operation.
Solution Approach 2:
The patent introduces an intermediary substance (the separation medium with selective binding properties) that mediates between the generator mixture and the purified radium product. This intermediary selectively interacts with actinium and thorium, allowing radium to pass through unbound, thereby simplifying the overall purification process while achieving high purity levels.
2Manufacturing precision
If multiple purification steps are implemented to achieve high purity, then radium-223 purity is improved, but production yield and efficiency deteriorate
Solution Approach 1:
The separation medium is pre-loaded with actinium and thorium during the loading phase before radium elution occurs. This preliminary action removes the bulk of contaminants in advance, so that subsequent washing and elution steps require fewer operations to achieve the same purity level, thereby maintaining higher production yield.
Solution Approach 2:
The patent recovers and reuses the actinium and thorium from the separation medium after the radium elution step. By discarding the purified radium product while recovering the generator materials (actinium and thorium) for regeneration, the process maintains high productivity and reduces waste, achieving both high purity and efficient production.
3Productivity
If the generator system is used continuously without regeneration, then production efficiency is maintained, but system lifespan and reliability deteriorate
Solution Approach 1:
The patent establishes a continuous cycle where the generator system is regenerated after each use. The actinium and thorium are recovered from the separation medium and the system is re-loaded, allowing continuous production operations. This continuity of useful action through regeneration maintains both high productivity and system reliability over extended periods.
Solution Approach 2:
The regeneration process provides feedback to the system by recovering the generator materials (actinium and thorium) from the separation medium and re-introducing them for another loading cycle. This feedback loop ensures the system maintains its functional state, extending lifespan while sustaining production efficiency.
4Manufacturing precision
If complex multi-step purification is used to achieve pharmaceutical grade purity, then radium-223 purity is improved, but production time and cost increase
Solution Approach 1:
The patent employs dynamic flow conditions during the purification process, utilizing both forward flow (for loading and washing) and reverse flow (for elution and regeneration). This dynamic approach optimizes contact times and separation efficiency, achieving pharmaceutical grade purity faster than static multi-step methods would require.
Solution Approach 2:
The patent changes key parameters including flow direction (forward and reverse), solution composition (acid concentration and type), and contact time to optimize the purification process. By adjusting these parameters, the system achieves high purity in reduced time compared to conventional fixed-parameter multi-step procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves pharmaceutical-grade purity of radium-223 with minimal contamination, high yield, and long-term viability, reducing radioactive waste and extending the generator system's lifespan by efficiently recovering and regenerating the actinium and thorium isotopes.
Implementation Method 1
A method utilizing a single diglycolamide (DGA) extraction step with both forward and reverse flow to separate radium-223 from actinium-227/Thorium-227 generator mixtures
Implementation Method 2
One radioactive decay chain leading to 223Ra, which has been used as a source for this isotope in small quantities
Data Source
AI summary
The present invention relates to a method for the generation of 223Ra of pharmaceutically tolerable purity comprising: i) preparing a generator mixture comprising 227Ac, 227Th and 223Ra in a first aqueous solution comprising a first mineral acid; ii) loading said generator mixture onto a DGA separation medium (e.g. resin); iii) eluting said 223Ra from said DGA separation medium using a second mineral acid in a second aqueous solution to give an eluted 223Ra solution; and iv) stripping the DGA separation medium of said 227Ac and 227Th by flowing a third mineral acid in a third aqueous solution through the DGA separation medium in a reversed direction; The invention further relates to high purity radium-223 formed or formable by such a method as well as pharmaceutical compositions comprising such radium-223 of pharmaceutical purity.